Skip to main content
. 2021 Nov 14;28(6):4686–4701. doi: 10.3390/curroncol28060395

Figure 2.

Figure 2

Figure 2

(A) Forest plot summarizing the proportion of patients with major pathological responses after neoadjuvant immunotherapy for resectable non-small cell lung cancer. (B) Forest plot summarizing the proportion of patients with complete pathological response of the primary tumor after neoadjuvant immunotherapy for resectable non-small cell lung cancer. (C) Forest plot summarizing the proportion of patients with complete pathological response of the primary tumor and sampled lymph nodes after neoadjuvant immunotherapy for resectable non-small cell lung cancer.